< Back to the list of products


Fevaxyn iCHP Chlam suspension for injection for cats

Description

Active substances: per 1 ml dose of vaccine Expressed as RP*
Feline Panleukopaenia Virus (CU4 strain) 9.5 - 12.25
Feline Calicivirus (255 strain) 1.65 - 2.15
Feline Rhinotracheitis Virus (605 strain) 1.60 - 2.10
Feline Chlamydia Psittaci (Cello Strain) 2.00 - 2.30
*RP = Relative Potency (as measured by ELISA)  
Adjuvants:
Ethylene/Maleic Anhydride (EMA) 10 mg
Neocryl XK-62 30 mg
Emulsigen SA 50 mg
Excipient:  
Eagles Earles/0.05% LAH to 1.0 ml

INDICATIONS

For the active immunisation of healthy cats and kittens against feline infectious enteritis (panleucopaenia), to reduce respiratory disease due to feline rhinotracheitis virus and calicivirus (cat flu) and pneumonia due to feline chlamydia psittaci.

CONTRAINDICATIONS

Do not use in unhealthy cats.

ADVERSE REACTIONS

A small percentage of vaccinated cats may develop post-vaccinal reactions including transient fever, listlessness and temporary swellings at the injection site, which usually disappear within 2 days.
In the event of an allergic reaction, immediate treatment should be given using adrenaline, corticosteroid or antihistamine.

TARGET SPECIES

Cats

DOSAGE, ROUTE AND METHOD OF ADMINISTRATION

The contents of the pre-filled syringe should be shaken well and administered aseptically by subcutaneous injection.
Dose: 1ml

Cats aged 8 weeks and older:For an initial vaccination course, two doses are required, injected at an interval of 3 - 4 weeks.
Booster Vaccination:Boost annually with a single dose of vaccine.

WITHDRAWAL PERIOD

Not applicable.

SHELF LIFE

Shelf life of the medicinal product as packaged for sale: 24 months
Use all contents of syringe immediately.

SPECIAL STORAGE PRECAUTIONS

Store and transport refrigerated (2°C - 8°C).
Protect from light.
Do not freeze.

SPECIAL WARNINGS

Do not vaccinate cats during pregnancy.
Do not mix with any other vaccine or immunological product.
No information is available on the safety and efficacy from the concurrent use of this vaccine with any other except those containing inactivated feline leukaemia virus. It is therefore recommended that no other vaccines than these should be administered within 14 days before or after vaccination with the product.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
To the user:

This product contains mineral oil. Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you.
If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician:
This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Any unused vaccine or waste material should be disposed of in accordance with local requirements.

OTHER INFORMATION

ATC Vet Code: QI06AL02
Nature and composition of immediate packaging
The product is presented in 3 ml disposable polypropylene syringes containing one 1 ml dose.
The syringes are sealed with rubber tips.
Pack Sizes
Syringes are supplied in packs of 10 or 25 syringes.

< Back to the list of products